Sales and Marketing

Showing 15 posts of 11524 posts found.

Ben_Mansfield_Marie_Pickford

Doctors.net.uk boosts team

August 2, 2010 Sales and Marketing appointment, doctors.net, sales and marketing

UK healthcare professional network Doctors.net.uk has appointed Marie Pickford and Ben Mansfield to its pharmaceutical team. Marie joins in a …
Amgen's Prolia

NICE halts Prolia appraisal

August 2, 2010 Sales and Marketing Amgen, NICE, Prolia

NICE says it has been forced to terminate a review of Amgen’s bone density drug Prolia after the US biotech …

FDA recommends Brilinta

July 30, 2010 Sales and Marketing 2010 financials, AstraZeneca, Brillinta, Q2

FDA advisors have voted in favour of AstraZeneca’s antiplatelet drug Brilinta, which is currently seeking a licence for the reduction …

Dr Bruce Burlington joins AZ board

July 30, 2010 Research and Development, Sales and Marketing AstraZeneca, appointment, research and development, sales and marketing

AstraZeneca has appointed former FDA staffer Dr Bruce Burlington to its board as a non-executive director. Dr Burlington spent 17 …

Sanofi’s blockbusters take a hit

July 29, 2010 Sales and Marketing 2010 financials, Genzyme, Q2, Sanofi-Aventis

Generic pressures, European pricing pressures and the impact of the US health reforms combined to dent Sanofi-Aventis’s growth in the …

UK lags behind Europe on innovative cancer drugs

July 29, 2010 Sales and Marketing Cancer, market access

The UK has been ranked as one of the worst countries when it comes to uptake of new cancer drug …

Merck KGaA’s oral MS therapy gains US priority review

July 29, 2010 Sales and Marketing Cladribine, MS, Merck KGaA

Merck’s cladribine has been granted a priority review status by the FDA in a move that could see it come …
Iressa

NICE approves trio of cancer drugs

July 28, 2010 Sales and Marketing Iressa, MabThera, NICE, Xeloda

NICE has given its final recommendation to a trio of drugs for the treatment of various cancers, which means the …

Lansley to create £50 million cancer drugs fund

July 28, 2010 Sales and Marketing Cancer, NHS, government, market access

The UK government is setting up a multi-million pound fund dedicated to improving patient access to innovative new cancer drugs. …
Genzyme

Genzyme ponders Sanofi offer

July 27, 2010 Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis is understood to have approached the board of Genzyme with a takeover bid for the company. News agency Reuters …

Generic Lovenox to dent Sanofi’s earnings

July 26, 2010 Sales and Marketing Lovenox, Sandoz, Sanofi-Aventis, generics

A generic version of Sanofi-Aventis’ blockbuster anti-blood clot treatment Lovenox has just gained approval in the US, signaling a rapid …

MSI promotes Michael Craig

July 26, 2010 Sales and Marketing MSI, appointment, sales and marketing

The MSI Consultancy has promoted Michael Craig to the role of senior consultant. In his new role he will be …

Novartis’ Christine Brennan joins Vitae

July 26, 2010 Sales and Marketing Vitae, appointment, sales and marketing

US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. She has over 10 years industry experience and …

IMS promotes Adel Al-Saleh to senior sales role

July 26, 2010 Sales and Marketing IMS, appointment, sales and marketing

IMS Health has promoted Adel Al-Saleh to the newly created position of senior vice president, sales and global account management. …

GSK’s Arixtra set for expanded licence

July 26, 2010 Sales and Marketing Arixtra, Avandia, GlaxoSmithKline, rotarix

GlaxoSmithKline is set to receive a green light to use its anti-clotting drug Arixtra to prevent spontaneous superficial-vein thrombosis (SVT). …
The Gateway to Local Adoption Series

Latest content